Featured Research

from universities, journals, and other organizations

'Less Is More' When It Comes To Treating High Blood Pressure

Date:
March 25, 2009
Source:
University of Western Ontario
Summary:
A newly published study found patients actually have more control of their high blood pressure (hypertension) when treated with less medication. The study recommends a simplified and more effective method of treating hypertension using low doses of single pill combinations, rather than multiple pills.

A newly published study found patients actually have more control of their high blood pressure (hypertension) when treated with less medication. The study led by Dr. Ross D. Feldman, a clinical scientist with the Robarts Research Institute at The University of Western Ontario recommends a simplified and more effective method of treating hypertension using low doses of single pill combinations, rather than multiple pills.

STITCH involved 2,104 patients with high blood pressure at 45 family practices in southwestern Ontario, Canada. Researchers wanted to see if there are simpler ways to help patients (and their doctors) reduce their blood pressure to goal levels than by following national guidelines which can be complicated. Feldman's study suggests that the majority of recently-diagnosed patients might better be served starting with a half tablet of a single pill combination drug (e.g. an ACE-inhibitor/diuretic or Angiotensin receptor blocker/diuretic combination) than the regular starting dose of a single drug.

"The nature of hypertension management has changed. It's much more aggressive, and complex, leading to hundreds of recommendations on how to manage high blood pressure," says Feldman, the R.W. Gunton Professor of Therapeutics at Western. "This should be a call to hypertensive patients to go to their family physicians to be prescribed these single pill combinations. It makes both the patients' and doctors' lives easier."

The proper diagnosis and treatment of high blood pressure can cut your risk of stroke by up to 40% and heart attack by up to 25%.

The "Simplified Treatment Intervention to Control Hypertension" (STITCH) study is in the April edition of the journal Hypertension.


Story Source:

The above story is based on materials provided by University of Western Ontario. Note: Materials may be edited for content and length.


Cite This Page:

University of Western Ontario. "'Less Is More' When It Comes To Treating High Blood Pressure." ScienceDaily. ScienceDaily, 25 March 2009. <www.sciencedaily.com/releases/2009/03/090319142431.htm>.
University of Western Ontario. (2009, March 25). 'Less Is More' When It Comes To Treating High Blood Pressure. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/03/090319142431.htm
University of Western Ontario. "'Less Is More' When It Comes To Treating High Blood Pressure." ScienceDaily. www.sciencedaily.com/releases/2009/03/090319142431.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins